Form 4: PROCEPT BioRobotics Corp: Director Stock Grant and Option Award

PROCEPT BioRobotics Corp reports a Form 4 filing detailing stock and option awards to Director Elisabeth Little.

Summary

• Director Elisabeth Little received 3,315 shares of Common Stock via Restricted Stock Units (RSUs) on June 9, 2026.
• These RSUs vest in full on the one-year anniversary of the grant date or the next annual meeting, whichever comes first, contingent on continued service.
• Additionally, Ms. Little was granted a stock option to purchase 5,853 shares of Common Stock at an exercise price of $28.78.
• This stock option also vests in full on the earlier of the one-year anniversary of the grant date or the next annual meeting, subject to continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents standard compensation practices for a director and does not contain new financial performance data or strategic shifts.

Positives

• Grant of restricted stock units and stock options to a director indicates a commitment to aligning executive incentives with shareholder value.
• The vesting schedule tied to continued service and annual meetings encourages long-term commitment and performance.
• The stock option exercise price of $28.78 suggests a potential for future appreciation if the stock price exceeds this level.

Negatives

• The filing does not provide information on the current market price of the stock, making it difficult to assess the immediate value of the awards.
• No details are provided regarding the rationale behind the specific number of shares or options granted.

Risks

• The value of the RSUs and stock options is subject to market fluctuations and the company's future stock performance.
• Failure to meet continued service requirements will result in forfeiture of the unvested awards.

Future Outlook

The future outlook for the value of these awards is dependent on the company's stock performance and the continued service of the director.

Industry Context

StockSavvy.ai notes that the issuance of stock options and RSUs to directors is a common practice in the biotechnology sector to incentivize long-term performance and align management interests with shareholders.

Stakeholder Impact

• Shareholders: The issuance of equity awards aligns director incentives with shareholder interests, potentially driving long-term value creation.
• Employees: Standard compensation practice that does not directly impact employees unless they are also recipients of similar awards.
• Management: Reinforces the alignment of executive compensation with company performance.

Next Steps

• Vesting of RSUs and stock options based on continued service and meeting the specified vesting conditions.

Key Dates

Keywords

Form 4, SEC Filing, PROCEPT BioRobotics Corp, PRCT, Stock Options, Restricted Stock Units, Director Compensation, Insider Trading, Beneficial Ownership